Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Diagnostic evaluation of separately acquired PET and CT images by nuclear medicine physicians and radiologists in cancer patients.

Quarles van Ufford HM, Quekel LG, van Waes PF, de Haas PJ, de Klerk JM.

Hell J Nucl Med. 2007 May-Aug;10(2):105-8.

PMID:
17684586
2.

Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT?

Reinartz P, Wieres FJ, Schneider W, Schur A, Buell U.

Eur J Nucl Med Mol Imaging. 2004 Nov;31(11):1456-61. Epub 2004 Jul 10.

PMID:
15248033
3.

Retrospective interactive rigid fusion of (18)F-FDG-PET and CT. Additional diagnostic information in melanoma patients.

Römer W, Nömayr A, Greess H, Fiedler E, Platsch G, Schuler-Thurner B, Pfahlberg A, Hothorn T, Schuler G, Hornegger J, Bautz W, Kuwert T.

Nuklearmedizin. 2006;45(2):88-95.

PMID:
16547570
4.

[Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].

Strunk H, Bucerius J, Jaeger U, Joe A, Flacke S, Reinhardt M, Hortling N, Palmedo H.

Rofo. 2005 Sep;177(9):1235-41. German.

PMID:
16123869
5.
6.

18FDG-PET in 733 consecutive patients with or without side-by-side CT evaluation: analysis of 921 lesions.

Buell U, Wieres FJ, Schneider W, Reinartz P.

Nuklearmedizin. 2004 Dec;43(6):210-6.

PMID:
15586217
7.

Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?

Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.

Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):331-8.

PMID:
18330088
8.

Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial.

Iagaru A, Mittra E, Mosci C, Dick DW, Sathekge M, Prakash V, Iyer V, Lapa P, Isidoro J, de Lima JM, Gambhir SS.

J Nucl Med. 2013 Feb;54(2):176-83. doi: 10.2967/jnumed.112.108803. Epub 2012 Dec 14.

10.

Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors.

Gerth HU, Juergens KU, Dirksen U, Gerss J, Schober O, Franzius C.

J Nucl Med. 2007 Dec;48(12):1932-9. Epub 2007 Nov 15.

11.

Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.

Grammaticos P, Zerva C, Asteriadis I, Trontzos C, Hatziioannou K.

Hell J Nucl Med. 2007 May-Aug;10(2):74-6.

PMID:
17684579
12.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
13.

PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.

Berthelsen AK, Holm S, Loft A, Klausen TL, Andersen F, Højgaard L.

Eur J Nucl Med Mol Imaging. 2005 Oct;32(10):1167-75. Epub 2005 May 21.

PMID:
15909196
14.

Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer.

Nakamoto Y, Sakamoto S, Okada T, Senda M, Higashi T, Saga T, Togashi K.

AJR Am J Roentgenol. 2007 Jan;188(1):257-67.

PMID:
17179375
15.

The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer.

Eschmann SM, Bitzer M, Paulsen F, Friedel G, Besenfelder H, Horger M, Reimold M, Dittmann H, Pfannenberg AC, Bares R.

Nucl Med Commun. 2004 Sep;25(9):909-15.

PMID:
15319596
16.

Software-based fusion of PET and CT images for suspected recurrent lung cancer.

Nakamoto Y, Senda M, Okada T, Sakamoto S, Saga T, Higashi T, Togashi K.

Mol Imaging Biol. 2008 May-Jun;10(3):147-53. doi: 10.1007/s11307-008-0131-x. Epub 2008 Feb 22.

PMID:
18293042
17.

Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study.

Pelosi E, Messa C, Sironi S, Picchio M, Landoni C, Bettinardi V, Gianolli L, Del Maschio A, Gilardi MC, Fazio F.

Eur J Nucl Med Mol Imaging. 2004 Jul;31(7):932-9. Epub 2004 Feb 27.

PMID:
14991245
18.

Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.

Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T, Bockisch A, Debatin JF, Freudenberg LS.

J Clin Oncol. 2004 Nov 1;22(21):4357-68.

PMID:
15514377
19.

Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.

Messa C, Ceresoli GL, Rizzo G, Artioli D, Cattaneo M, Castellone P, Gregorc V, Picchio M, Landoni C, Fazio F.

Q J Nucl Med Mol Imaging. 2005 Sep;49(3):259-66.

20.

Granulomatous disease: is it a nuisance or an asset during PET/computed tomography evaluation of lung cancers?

Chundru S, Wong CY, Wu D, Balon H, Palka J, Chang CY, Gaskill M, Cheng CY, Huang WS, Fink-Bennett D.

Nucl Med Commun. 2008 Jul;29(7):623-7. doi: 10.1097/MNM.0b013e3282fdc979.

PMID:
18528184

Supplemental Content

Support Center